ACACIA RESEARCH CORP
CIK 934549 · last filed 2020-06-09
ACACIA RESEARCH CORP is a corporate insider who has filed 10 SEC Form 4 insider transactions across 3 companies since 2017. The most recent filing shows the insider sold $29.3M of EVFM on Jun 9, 2020. Across all open-market trades the lifetime net is −$51.6M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $501.9K across reported positions. The firm reports its address in New York, NY. 99 SEC filings were submitted jointly with Paul R Ryan.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
EVFM price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
SUITE 2602
NEW YORK, NY 10017
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Evofem Biosciences, Inc. (EVFM) Delisted | 10%+ Owner | 1 | $0.01 | $0 | -$29.33M | 1 | 2020-06-09 |
| Drive Shack Inc. (DS) Delisted | Director | 574,100 | $0.17 | $96.2K | $2.35M | 2 | 2019-12-26 |
| VERI | 10%+ Owner | 884,772 | $0.57 | $501.9K | -$24.60M | 7 | 2019-01-15 |
Recent Filings
10 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-06-09 | Evofem Biosciences, Inc. (EVFM) Delisted | Sell (S) | −9,138,504 | -$29.33M | EDGAR |
| 2019-12-26 | Drive Shack Inc. (DS) Delisted | Buy (P) | +74,100 | $276.4K | EDGAR |
| 2019-11-18 | Drive Shack Inc. (DS) Delisted | Buy (P) | +500,000 | $2.08M | EDGAR |
| 2019-01-15 | VERI | Sell (S) | −534,748 | -$2.67M | EDGAR |
| 2019-01-14 | VERI | Sell (S) | −534,748 | -$2.67M | EDGAR |
| 2018-12-13 | VERI | Sell (S) | −200,000 | -$1.24M | EDGAR |
| 2018-12-03 | VERI | Sell (S) | −1,500,000 | -$7.51M | EDGAR |
| 2018-08-27 | VERI | Sell (S) | −1,000,000 | -$10.50M | EDGAR |
| 2017-05-26 | VERI | Mixed | +3,969,521 | $54.02M | EDGAR |
| 2017-05-19 | VERI | Mixed | +3,969,521 | $54.02M | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.